News

Albany Molecular Research, Inc. (AMRI), a leading global provider of advanced contract research, development and manufacturing solutions, announced that the company has been chosen to support the development and manufacture of lipid excipients for the Pfizer-BioNTech COVID-19 vaccine. For the...

Malvern Panalytical, a leading analytical instruments and services supplier, launches a new version of its Aeris compact X-ray diffractometer (XRD). Aeris is a small-footprint system with a big heart, and even bigger ambitions. This new version contains capabilities previously...

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announces it is making new capital investments to increase capacity at its owned and partnered manufacturing facilities, which it expects will increase global 2022 capacity to approximately...

AiCure and OncoBay Clinical announced a partnership to provide oncology sponsors with scalable, AI-powered insights to improve patient care and optimize drug development. A subsidiary of the Moffitt Cancer Center, OncoBay will make AiCure's proprietary AI platform available for...

Sygnature Discovery has begun expanding into new state of the art laboratories at Alderley Park, Cheshire, adding Chemistry and Biology expertise to its DMPK and Translational Oncology teams already present on the site. Creating truly integrated interdisciplinary teams, co-located in...

Albany Molecular Research, Inc. (AMRI), a leading global provider of advanced contract research, development and manufacturing solutions,  announced that the company has been chosen to support the development and manufacture of lipid excipients for the Pfizer-BioNTech COVID-19 vaccine. For the...

Calyx, the eClinical and regulatory solutions and services provider most relied on for solving complex data challenges in clinical research, today announced a scientific consulting program aimed at optimizing imaging processes and outcomes to accelerate the clinical development of...